SEC
SlamSEC
SearchBrowseEarnings

MARIZYME, INC.

OTC:MRZM
Surgical & Medical Instruments & Apparatus·JUPITER, FL
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Revenue
$233,485
+11.0% YoY
FY 2023
Adj. EBITDA
-$37.3M
-15966.7% margin
FY 2023
Net Income
-$38.2M
-16346.2% margin
FY 2023
EPS (Diluted)
-$0.94
FY 2023
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$4.1M
FY 2022
Total Debt
$830,350
FY 2011
Net Cash
$3.2M
FY 2011
Enterprise Value
—
Debt / EBITDA
0.1x
FY 2023
EV / EBITDA
—
Employees
—